Here’s a quick look at major corporate developments impacting the Indian stocks. From Jio Financial’s full acquisition of Jio Payments Bank to HDFC Bank’s leadership change and upcoming IPO, key companies are making strategic moves. Updates also include Hero MotoCorp’s EV launch, Tata Elxsi’s EV tech partnership, Vodafone Idea’s satellite broadband deal, and Abbott India’s pharma distribution tie-up. These developments could influence market sentiment and select stocks today.
Stocks on June 19, 2025
Jio Financial Services
Jio Financial Services has acquired 7.91 crore equity shares of Jio Payments Bank from SBI for ₹104.54 crore. With RBI’s approval on June 4, the deal makes Jio Payments Bank a wholly owned subsidiary, ending its joint venture with SBI and strengthening Jio’s digital banking footprint.
HDFC Bank
HDFC Bank announced the resignation of its Chief Human Resource Officer, Vinay Razdan, effective after business hours on June 18, 2025. Meanwhile, trading in shares of its NBFC arm, HDB Financial Services, has been frozen ahead of its anticipated IPO filing.
Hero MotoCorp
Hero MotoCorp is set to launch its Vida VX2 electric scooter on July 1, 2025. The model will be offered with a Battery-as-a-Service (BaaS) option to reduce upfront ownership costs. The launch will be supported by the company’s EV network in 100+ cities.
Tata Elxsi
Tata Elxsi has entered a partnership with Infineon Technologies to co-develop EV solutions for the Indian market. The collaboration focuses on building cost-effective, safety-compliant subsystems to accelerate electric vehicle adoption.
Bank of Maharashtra
Bank of Maharashtra has entered into a partnership with SBI Cards to launch co-branded credit cards. These offerings will be customized to meet the evolving financial and lifestyle needs of its customers.
Vodafone Idea
Vodafone Idea has partnered with AST SpaceMobile to bring direct-to-device satellite broadband to India. This initiative will provide mobile connectivity via satellite to standard smartphones, supporting the Digital India mission.
ABBOTT India
Abbott India has signed a distribution deal with MSD Pharmaceuticals to market sitagliptin-based diabetes drugs like, Januvia, Janumet, and Janumet XR. The agreement aims to expand access to Type 2 diabetes treatments across India using Abbott’s extensive distribution network.
